TOP NEWS: AstraZeneca Gets Two Cancer Drugs Approvals In Japan
LONDON (Alliance News) - AstraZeneca PLC said Monday it got two new approvals in Japan for the use of PARB inhibitor Lynparza in breast cancer and lung cancer immunotherapy Imfinzi.The FTSE Read More